SymbolCLPT
NameCLEARPOINT NEURO, INC.
SectorHEALTH CARE
RegionNorth America
IndustrySurgical & Medical Instruments & Apparatus
Address120 S. SIERRA AVENUE, SOLANA BEACH, CA 92075
Telephone9499006833
Fax
Email
Websitehttps://www.clearpointneuro.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001285550
Description

ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Companys flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

Additional info from NASDAQ:
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Companys flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

2026-07-31 20:05

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel

Read more
2026-07-21 20:05

ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026

Read more
2026-07-07 00:05

FLETCHER R JOHN 🟢 acquired 662 shares of ClearPoint Neuro, Inc. (CLPT) at $17.84 Transaction Date: Jul 01, 2026 | Filing ID: 296615

Read more
2026-07-07 00:05

Richards Timothy T. 🟢 acquired 222 shares of ClearPoint Neuro, Inc. (CLPT) at $17.84 Transaction Date: Jul 01, 2026 | Filing ID: 296614

Read more
2026-07-02 20:05

STIGALL L. JEREMY 🟢 acquired 1.8K shares of ClearPoint Neuro, Inc. (CLPT) at $11.93 Transaction Date: Jun 30, 2026 | Filing ID: 294477

Read more
2026-07-02 20:05

D'Alessandro Danilo 🟢 acquired 1.1K shares of ClearPoint Neuro, Inc. (CLPT) at $11.93 Transaction Date: Jun 30, 2026 | Filing ID: 294476

Read more
2026-07-02 20:05

BURNETT JOSEPH 🟢 acquired 1.4K shares of ClearPoint Neuro, Inc. (CLPT) at $11.93 Transaction Date: Jun 30, 2026 | Filing ID: 294474

Read more
2026-06-29 20:42

📋 JOSEPH BURNETT (Director) plans to sell 20K shares of CLEARPOINT NEURO INC (at $18.48 each, total $370K) Filed: Jun 29, 2026 | ID: 006598

Read more
2026-06-22 20:05

BURNETT JOSEPH 🟡 adjusted position in 61.8K shares (1 derivative) of ClearPoint Neuro, Inc. (CLPT) at $17.94 ($1.4M) Transaction Date: Jun 17, 2026 | Filing ID: 277503

Read more
2026-06-17 20:33

📋 JOSEPH M BURNETT TRUST (Affiliate of Director) plans to sell 2K shares of ClearPoint Neuro, Inc. (at $13.34 each, total $25K) Filed: Jun 17, 2026 | ID: 006274

Read more